Equitable Holdings’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,021
Closed -$205K 1714
2025
Q4
$205K Buy
+2,021
New +$162K ﹤0.01% 1492
2024
Q2
Sell
-3,301
Closed -$228K 1222
2024
Q1
$228K Buy
3,301
+121
+4% +$7.65K ﹤0.01% 1050
2023
Q4
$235K Sell
3,180
-750
-19% -$49.2K ﹤0.01% 1013
2023
Q3
$268K Buy
3,930
+25
+0.6% +$2.12K ﹤0.01% 900
2023
Q2
$367K Sell
3,905
-10,956
-74% -$855K 0.01% 787
2023
Q1
$1.01M Buy
+14,861
New +$955K 0.02% 465
2021
Q4
Sell
-2,803
Closed -$268K 865
2021
Q3
$268K Buy
2,803
+733
+35% +$77.4K ﹤0.01% 709
2021
Q2
$257K Sell
2,070
-1,509
-42% -$180K ﹤0.01% 709
2021
Q1
$472K Buy
3,579
+1,504
+72% +$206K 0.01% 520
2020
Q4
$275K Buy
2,075
+76
+4% +$9.19K 0.01% 582
2020
Q3
$204K Sell
1,999
-3,771
-65% -$326K 0.01% 592
2020
Q2
$502K Buy
5,770
+1,511
+35% +$121K 0.01% 404
2020
Q1
$247K Sell
4,259
-734
-15% -$59.6K 0.01% 502
2019
Q4
$462K Buy
+4,993
New +$439K 0.01% 416

Other funds holding EXAS

Equitable Holdings's EXAS Position: Q1 2026 in Review

Equitable Holdings sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2,021 shares — an estimated $205K sold.

Equitable Holdings first reported a position in EXAS in Q4 2019 and held it in 14 quarters. The position peaked at $1.01M in Q1 2023. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Equitable Holdings reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Equitable Holdings sold 2,021 Exact Sciences shares in Q1 2026, an estimated $205K.
  • Equitable Holdings first reported a position in Exact Sciences in Q4 2019 and held it in 14 quarters.
  • Equitable Holdings's Exact Sciences position peaked at $1.01M in Q1 2023.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Equitable Holdings's 13F filing for Q1 2026, filed 15 May 2026.